Matthew Brams, EVP and Chief Medical Officer at Cingulate Inc. (CING), bought 1,946 shares at $5.04 ($10K) on 2026-02-06, disclosed to the SEC on 2026-02-10.
Open-market purchase of $10k CING by EVP and Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.